Search

Search Constraints

You searched for: Author/Creator Colas, Eva

Search Results

1. Molecular diagnosis of endometrial cancer from uterine aspirates. Issue 10 (21st June 2013)

2. 2022-RA-997-ESGO Lung recurrence of endometrial adenocarcinoma: impact of molecular profile and role of local therapies on prognosis. (20th October 2022)

3. 37/#877 Hormonal biomarkers remain prognostic relevant within the molecular classification in endometrial cancer. (4th December 2022)

4. Added Value of Estrogen Receptor, Progesterone Receptor, and L1 Cell Adhesion Molecule Expression to Histology-Based Endometrial Carcinoma Recurrence Prediction Models: An ENITEC Collaboration Study. Issue 3 (1st March 2018)

5. Added Value of Estrogen Receptor, Progesterone Receptor, and L1 Cell Adhesion Molecule Expression to Histology-Based Endometrial Carcinoma Recurrence Prediction Models: An ENITEC Collaboration Study. Issue 3 (March 2018)

6. Advances in endometrial cancer protein biomarkers for use in the clinic. (2nd January 2018)

7. Annexin‐A2 as predictor biomarker of recurrent disease in endometrial cancer. Issue 8 (29th September 2014)

8. Integrated genome analysis of uterine leiomyosarcoma to identify novel driver genes and targetable pathways. Issue 6 (7th November 2017)

9. Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early‐stage endometrioid endometrial cancer. Issue 4 (23rd January 2017)

10. Exosome-like vesicles in uterine aspirates: a comparison of ultracentrifugation-based isolation protocols. Issue 1 (December 2016)